
Charlotte Huggett reviews a recent Canadian population-based cohort study, which examines rates of suicide and self-harm in adult survivors of critical illness.
[read the full story...]Charlotte Huggett reviews a recent Canadian population-based cohort study, which examines rates of suicide and self-harm in adult survivors of critical illness.
[read the full story...]Nada Abou Seif summarises a network meta-analysis which finds that EMDR and trauma-focused CBT remain the most effective ways to treat adult PTSD.
[read the full story...]Shania Lorenz summarises a recent UK population-based cohort study which used National Health Service data to find a 787% increase in autism diagnoses over the past 20 years.
[read the full story...]Andie Ashdown summarises a qualitative study exploring ethnic minority groups’ experiences of suicide bereavement.
[read the full story...]Sharon Eager summarises a qualitative study conducted with university students in South Africa who identify the pros and cons of iCBT for depression.
[read the full story...]Maria Loades and Georgia Herring consider a randomised trial of online single-session interventions for adolescent depression during COVID-19.
[read the full story...]In her debut blog, Tanya Garg summarises a systematic review that suggests trauma-focused CBT may be helpful for people with PTSD symptoms who are also experiencing an ongoing threat of trauma.
[read the full story...]In her debut blog, Christine Purdon explores a model of checking compulsions in those with OCD, finding that severity and likelihood of harm are important. This research led by Adam Radomsky will be presented at the #BABCP2022 conference in London later this week.
[read the full story...]Dona Matthews reviews a paper on an evidence-based theory of psychological adjustment to long-term physical health conditions and applications in clinical practice, which will be presented at the #BABCP2022 conference in London later this week.
[read the full story...]In her debut blog, Sally Turner considers a recent study on cannabis use and clinical outcomes in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
[read the full story...]